NewsAsarfi Hospital Reports FY26 Audited Results: Revenue at ₹17,319.69 Lakhs, Net Profit at ₹1,707.66 LakhsAsarfi Hospital Reports FY26 Audited Results: Revenue at ₹17,319.69 Lakhs, Net Profit at ₹1,707.66 Lakhs
Asarfi Hospital Limited reported strong FY26 audited results with standalone revenue from operations at ₹17,319.69 lakhs and net profit after tax at ₹1,707.66 lakhs, up from ₹12,177.76 lakhs and ₹1,097.96 lakhs respectively in the prior year. On a consolidated basis, revenue stood at ₹17,350.29 lakhs and net profit at ₹1,666.09 lakhs. Statutory auditors M/s R. K. Thakkar & Co. issued unmodified audit opinions on both standalone and consolidated financial statements.
*this image is generated using AI for illustrative purposes only.
Asarfi Hospital Limited's Board of Directors, at its meeting held on May 11, 2026, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 03:00 P.M. and concluded at 5:30 P.M. The statutory auditors, M/s R. K. Thakkar & Co., Chartered Accountants (FRN: 002690C), issued audit reports with unmodified opinion on both the standalone and consolidated financial statements, as declared by the company under Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015.
Standalone Financial Performance
On a standalone basis, Asarfi Hospital delivered a strong performance for the financial year ended March 31, 2026. Revenue from Operations grew significantly to ₹17,319.69 lakhs from ₹12,177.76 lakhs in the previous year. Total Income, including other income of ₹278.46 lakhs, stood at ₹17,598.15 lakhs. The company's net profit after tax rose to ₹1,707.66 lakhs from ₹1,097.96 lakhs in the prior year. The following table summarises the key standalone financial metrics:
| Metric: | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Revenue from Operations: | ₹17,319.69 lakhs | ₹12,177.76 lakhs |
| Other Income: | ₹278.46 lakhs | ₹635.71 lakhs |
| Total Income: | ₹17,598.15 lakhs | ₹12,813.47 lakhs |
| Total Expenses: | ₹15,337.20 lakhs | ₹11,342.01 lakhs |
| Profit Before Tax: | ₹2,260.95 lakhs | ₹1,471.45 lakhs |
| Net Profit After Tax: | ₹1,707.66 lakhs | ₹1,097.96 lakhs |
| Basic EPS (₹10 face value): | ₹8.68 | ₹5.58 |
| Diluted EPS (₹10 face value): | ₹8.68 | ₹5.58 |
Consolidated Financial Performance
On a consolidated basis, which includes subsidiary Asarfi Educational Foundation, the group reported Revenue from Operations of ₹17,350.29 lakhs and Total Income of ₹17,620.46 lakhs for the financial year ended March 31, 2026. Consolidated net profit after tax stood at ₹1,666.09 lakhs compared to ₹1,057.61 lakhs in the previous year. The key consolidated financial metrics are presented below:
| Metric: | FY26 (Audited) | FY25 (Audited) |
|---|---|---|
| Revenue from Operations: | ₹17,350.29 lakhs | ₹12,177.76 lakhs |
| Other Income: | ₹270.17 lakhs | ₹630.80 lakhs |
| Total Income: | ₹17,620.46 lakhs | ₹12,808.56 lakhs |
| Total Expenses: | ₹15,401.09 lakhs | ₹11,377.47 lakhs |
| Profit Before Tax: | ₹2,219.37 lakhs | ₹1,431.09 lakhs |
| Net Profit After Tax: | ₹1,666.09 lakhs | ₹1,057.61 lakhs |
| Basic EPS (₹10 face value): | ₹8.47 | ₹5.37 |
| Diluted EPS (₹10 face value): | ₹8.47 | ₹5.37 |
Balance Sheet Highlights
The standalone balance sheet as at March 31, 2026 reflects total assets of ₹19,389.27 lakhs, up from ₹16,430.57 lakhs as at March 31, 2025. Shareholders' funds stood at ₹9,851.39 lakhs, comprising share capital of ₹1,967.73 lakhs and reserves and surplus of ₹7,883.66 lakhs. On the consolidated basis, total assets were ₹19,316.02 lakhs as at March 31, 2026, compared to ₹16,388.67 lakhs in the previous year. Key balance sheet parameters are summarised below:
| Parameter: | Standalone FY26 | Standalone FY25 | Consolidated FY26 | Consolidated FY25 |
|---|---|---|---|---|
| Total Assets: | ₹19,389.27 lakhs | ₹16,430.57 lakhs | ₹19,316.02 lakhs | ₹16,388.67 lakhs |
| Shareholders' Funds: | ₹9,851.39 lakhs | ₹8,143.73 lakhs | ₹9,764.41 lakhs | ₹8,098.32 lakhs |
| Long-term Borrowings: | ₹3,500.88 lakhs | ₹3,382.93 lakhs | ₹3,500.88 lakhs | ₹3,382.93 lakhs |
| Trade Receivables: | ₹5,406.67 lakhs | ₹3,979.73 lakhs | ₹5,412.15 lakhs | ₹3,979.73 lakhs |
| Cash and Bank Balances: | ₹1,293.71 lakhs | ₹1,430.93 lakhs | ₹1,305.67 lakhs | ₹1,442.00 lakhs |
Cash Flow and Auditor Details
The standalone cash flow statement reflects net cash generated from operating activities of ₹1,909.38 lakhs for the year ended March 31, 2026, compared to a net cash outflow of ₹383.67 lakhs in the previous year. The closing balance of cash and cash equivalents on a standalone basis stood at ₹610.05 lakhs. On a consolidated basis, net cash from operating activities was ₹1,830.43 lakhs, with a closing cash and cash equivalents balance of ₹622.01 lakhs. The audit was conducted by M/s R. K. Thakkar & Co., Chartered Accountants, Dhanbad, with partner H K Dokania (Membership No. 415931) signing the reports dated May 11, 2026. The company has only one reportable segment — Hospital — as per Accounting Standard 17 on Segment Reporting. The results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 11, 2026.
Trading Window and Compliance
In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct, Asarfi Hospital Limited has maintained a trading window closure for its designated persons from April 1, 2026 to May 31, 2026 (both days inclusive). The filing was submitted by CS Sudipa Singh, Company Secretary and Compliance Officer (Membership No. ACS 56989), on behalf of the company. Asarfi Hospital Limited is headquartered in Dhanbad, Jharkhand, and operates under CIN: L85110JH2005PLC011673.
Historical Stock Returns for Asarfi Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +8.27% | -9.34% | +15.76% | +65.67% | +120.94% |
Given Asarfi Hospital's ~42% revenue growth in FY26, what expansion plans or capacity additions is the management considering to sustain this growth trajectory into FY27?
With trade receivables rising sharply from ₹3,979 lakhs to ₹5,406 lakhs against revenue growth, how might deteriorating debtor collection cycles impact the company's working capital and liquidity position going forward?
As long-term borrowings have increased to ₹3,500 lakhs, are there plans for further debt-funded capital expenditure, and how could rising interest costs affect future profitability margins?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
